Teleflex Incorporated ($TFX) Stock Forecast: Down 5.1% Today

What is Teleflex Incorporated?

TFX is a pharmaceutical company specializing in medical devices and treatments. Today, the stock had a strong bearish movement.

Why is Teleflex Incorporated going down?

TFX stock is down 5.1% on Sep 15, 2025 18:15

• The enrollment of the first patient in the DUBSTENT DIABETES trial, focusing on improving PCI outcomes for diabetic patients, could be seen as a positive development for TFX.
• However, the market might have reacted negatively to the uncertainty surrounding the trial's success and potential regulatory hurdles.
• Investors may be concerned about the competitive landscape in the diabetes treatment market, leading to a sell-off of TFX shares.
• Overall, the bearish movement in TFX's stock could be attributed to the mixed sentiments surrounding the trial's outcomes and the competitive pressures in the industry.

TFX Price Chart

TFX Technical Analysis

TFX News

First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients

The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and ...

https://www.globenewswire.com/news-release/2025/09/11/3148410/0/en/First-Patient-Enrolled-in-DUBSTENT-DIABETES-Trial-Targeting-Improved-PCI-Outcomes-for-Diabetic-Patients.html

Trending Today

Binance Coin ($BNB) Crypto Forecast: Up 5.0% Today

Teleflex Incorporated Price History

25.08.2024 - TFX Stock was up 0.7%

• Comparisons with EW indicate that TFX might be the better value option at the moment.
• Optimism about TFX's performance in the Interventional category and its potential in Asia has positively influenced investors.
• This optimism and potential value could be factors behind the bullish movement in TFX's stock today.

01.10.2024 - TFX Stock was up 5.3%

• TFX displayed a robust bullish trend today despite revising its 2024 revenue forecast downwards.
• Exceeding Q3 earnings projections and declaring a quarterly dividend likely bolstered investor confidence in the company's stock.
• The introduction of new vascular access products in Canada may have indicated growth prospects for TFX, playing a role in the positive market performance.
• The stock's upward movement seems influenced by favorable earnings results and strategic product introductions, potentially overshadowing concerns about the reduced revenue expectations.

15.08.2025 - TFX Stock was down 5.1%

• The enrollment of the first patient in the DUBSTENT DIABETES trial, focusing on improving PCI outcomes for diabetic patients, could be seen as a positive development for TFX.
• However, the market might have reacted negatively to the uncertainty surrounding the trial's success and potential regulatory hurdles.
• Investors may be concerned about the competitive landscape in the diabetes treatment market, leading to a sell-off of TFX shares.
• Overall, the bearish movement in TFX's stock could be attributed to the mixed sentiments surrounding the trial's outcomes and the competitive pressures in the industry.

08.04.2025 - TFX Stock was up 5.4%

• A Board Member at Teleflex, Duncan, displayed confidence in the company's future prospects by acquiring stock options.
• Teleflex's Q1 earnings exceeded expectations due to its diverse product portfolio and strong performance in key segments, fostering investor optimism.
• Despite an investigation by the Rosen Law Firm concerning potential securities claims, Teleflex's stock performance remained largely unaffected, with positive earnings results taking precedence.

28.01.2025 - TFX Stock was down 5.8%

• Surpassing Q4 earnings estimates and benefiting from a diversified product portfolio, TFX faced a bearish movement possibly due to a decline in gross margin.
• The announcement of the planned retirement of the Chief Financial Officer may have prompted concerns among investors regarding future financial strategies and leadership stability.
• While the quarterly dividend declaration was favorable, it may not have been enough to counter the impact of the CFO's retirement and the gross margin decline on investor sentiment.
• Overall, market participants seem to be taking a cautious approach towards TFX's future financial performance and strategic direction, influencing the stock price to move bearishly.

01.04.2025 - TFX Stock was down 6.3%

• Despite beating Q1 earnings and revenue estimates, the stock experienced a bearish movement, indicating that the market may have had higher expectations.
• The FDA clearance for expanded indications of one of Teleflex's medical devices may not have had the positive impact on the stock price as anticipated.
• The ongoing investigation by Pomerantz Law Firm into claims on behalf of investors could have raised concerns among shareholders, leading to the bearish market movement.
• Overall, the combination of high expectations, mixed reactions to regulatory news, and investor scrutiny may have contributed to the bearish trend in TFX stock today.

01.04.2025 - TFX Stock was down 5.1%

• The bearish movement in TFX stock could be due to investor concerns raised by the ongoing investigation by Pomerantz Law Firm regarding claims on behalf of investors.
• Despite the positive news of FDA clearance for expanded indications of their medical device, the uncertainty surrounding the investigation might have overshadowed the potential market impact.
• Investors may be cautious until more clarity is provided on the outcome of the investigation, leading to the downward movement in TFX stock price today.

18.01.2025 - TFX Stock was up 1.9%

• Teleflex's participation in the Raymond James & Associates 46th Annual Institutional Investors Conference is believed to have positively influenced investor sentiment, hinting at possible growth opportunities or favorable developments within the company.
• The upcoming conference presentation could serve as a platform for Teleflex to showcase its latest innovations, products, and strategic plans, possibly leading investors to expect strong performance and promising future prospects.
• Furthermore, the scheduled conference call to discuss the fourth quarter financial results and operational update may have fostered confidence among investors regarding the company's financial well-being and operational effectiveness, thereby contributing to the bullish movement in TFX stock.

31.09.2024 - TFX Stock was down 15.8%

• Despite surpassing Q3 earnings estimates, Teleflex saw a decline in its stock price.
• The company's announcement of a quarterly dividend is typically a show of confidence in its financial standing, yet it was not enough to counteract the bearish trend.
• The introduction of new vascular access devices in Canada may have been a positive move, but other factors appear to have influenced the stock's decline.
• Investor response to general market conditions or industry-specific challenges could be contributing to the downward trend in TFX stock, despite positive developments.

08.06.2025 - TFX Stock was up 1.9%

• The acquisition of BIOTRONIK's vascular intervention business by Teleflex (TFX) resulted in a 2.9% increase in TFX stock price.
• This acquisition is viewed as a strategic move to improve TFX's presence in cath lab and its innovation pipeline.
• Investor confidence in TFX's growth prospects was positively influenced by this acquisition.

27.01.2025 - TFX Stock was down 17.3%

• The downward trend in TFX stock today may be linked to profit-taking by investors following the stock's surpassing of Q4 earnings expectations. Positive news can sometimes trigger short-term selling pressure.
• Concerns among investors about potential changes in company leadership and future financial strategies may have arisen following the announcement of Thomas Powell's retirement as Chief Financial Officer.
• The market's uncertainty and volatility could have been influenced by Teleflex's announcement of its intention to split into two separate publicly traded entities, potentially impacting the stock's bearish movement.
• The amalgamation of these elements, combined with prevailing market conditions, likely played a role in the downward trajectory of TFX stock today.

31.06.2025 - TFX Stock was up 6.6%

• TFX stock saw a significant increase in value today.
• The company's Q2 earnings and revenues exceeded expectations, reflecting robust financial results.
• The recent declaration of a quarterly dividend by Teleflex's Board of Directors may have enhanced investor trust and drawn more interest from potential buyers to the stock.
• Both the impressive earnings performance and the dividend declaration likely contributed to the positive movement in TFX's stock price.